CACNA1C and atherosclerosis: Thus, the switch of the CACNA1C alterative splicing from exon 21 to exon 22 (Figure 3(b)) is a molecular signature of the Cav1.2 remodeling of VSM cells to a pathophysiological proliferating state in atherosclerosis.